Clinical trial
Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis
NCT07394257 is registered in ClinicalTrials.gov with Minia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis
- Lead sponsor
- Minia University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 1, 2025
- Completion date
- October 1, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bacterial keratitis, corneal ulcer, recalcitrant infectious keratitis